Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trialTheodore W. Laetsch, Andrew C. Harris, André Baruchel et al.|The Lancet Oncology|2019Cited by 90